GLAXO / NSE / Biotechnology & Drugs
GlaxoSmithKline Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High3,515.95
Target Low2,155
Target Mean2
Target Median25
Risk Metrics
Overall RiskBalanced risk
Board Risk25.05
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Glaxosmithkline Pharmaceuticals Ltd Faces Bearish Momentum Amid Technical Downgrade Markets Mojo
Glaxosmithkline Pharmaceuticals Ltd is Rated Sell Markets Mojo
GSK Pharma recommends ₹57 dividend, sets AGM date scanx.trade
Five Consecutive Losses Push Glaxosmithkline Pharmaceuticals Ltd to a New 52-Week Low Markets Mojo
Markets Rally, But Glaxosmithkline Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off Markets Mojo
GSK Pharma Compliance Officer resigns effective August 5, 2026 scanx.trade
Glaxosmithkline Pharmaceuticals Ltd Falls to 52-Week Low of Rs 2215 as Sell-Off Deepens Markets Mojo
Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

